Sopan Pharmaceuticals to issue IPO on April 15

Apr 01, 2026 09:17 AM Merolagani



Sopan Pharmaceuticals is set to issue initial public offering (IPO) to the general public on April 15.

The company obtained approval to issue 25 percent of ordinary shares of its issued capital of Rs 1.71 billion. Accordingly, it will issue 4,290,000 units of shares worth Rs 429 million to the general public.

Out of total approved units, the company already issued 429,000 units of shares worth Rs 42.9 million to foreign migrated workers. Moreover, the company secured 214,500 units to mutual funds and 171,600 units to employees.

Now in the second phase, the company is issuing 3,474,900 units to the general public.

Interested investors can apply for a minimum of 10 units and maximum of 11,000 units of shares. The issue will close early on April 19 and lately on April 29.

The company has appointed NMB Capital as issue manager. The interested investors can apply from all C-ASBA approved BFIs and Meroshare.

Care Ratings Nepal has assigned B rating to the issuer indicating high risks.

 




Gold and Silver Price Decline

Mar 30, 2026 10:46 AM

The gold and silver price have decreased on March 30.

Gold and Silver Price Gain

Mar 31, 2026 10:53 AM

Gold and Silver Price Gain

Mar 29, 2026 11:07 AM